Page 56 - IMO-2-2
P. 56
Innovative Medicines & Omics Alzheimer’s disease and clinical trials
of tramiprosate in Alzheimer’s disease are associated with into neuroinflammation involved in pathogenic mechanism
higher number of APOE4 alleles: The “APOE4 gene-dose of Alzheimer’s disease and its potential for therapeutic
effect”. J Prev Alzheimers Dis. 2016;3:219-228. intervention. Cells. 2022;11:1925.
doi: 10.14283/jpad.2016.115 doi: 10.3390/cells11121925
143. Manzano S, Aguera L, Aguilar M, Olazaran J. A review on 145. Bogar F, Fulop L, Penke B. Novel therapeutic target for
tramiprosate (Homotaurine) in Alzheimer’s disease and prevention of neurodegenerative diseases: Modulation
other neurocognitive disorders. Front Neurol. 2020;11:614. of neuroinflammation with Sig-1R ligands. Biomolecules.
doi: 10.3389/fneur.2020.00614 2022;12:363.
144. Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z. New insights doi: 10.3390/biom12030363
Volume 2 Issue 2 (2025) 50 doi: 10.36922/IMO025050007
